Paying users zone. Data is covered by hidden.

  • Get to Allergan PLC for $15.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Statement of Financial Position, Assets

Difficulty: Beginner

The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Allergan PLC, Consolidated Statement of Financial Position, Assets

USD $ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Cash and cash equivalents hidden hidden hidden hidden hidden
Short-term investments hidden hidden hidden hidden hidden
Teva shares hidden hidden hidden hidden hidden
Marketable securities hidden hidden hidden hidden hidden
Accounts receivable, net hidden hidden hidden hidden hidden
Inventories hidden hidden hidden hidden hidden
Prepaid taxes hidden hidden hidden hidden hidden
Prepaid insurance hidden hidden hidden hidden hidden
Royalty receivables hidden hidden hidden hidden hidden
Sales and marketing hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Prepaid expenses and other current assets hidden hidden hidden hidden hidden
Current assets held for sale hidden hidden hidden hidden hidden
Deferred tax assets hidden hidden hidden hidden hidden
Current assets hidden hidden hidden hidden hidden
Property, plant and equipment, net hidden hidden hidden hidden hidden
Legacy Allergan Deferred executive compensation investments hidden hidden hidden hidden hidden
Equity method investments hidden hidden hidden hidden hidden
Cost method investments hidden hidden hidden hidden hidden
Other long-term investments hidden hidden hidden hidden hidden
Taxes receivable hidden hidden hidden hidden hidden
Other assets hidden hidden hidden hidden hidden
Investments and other assets hidden hidden hidden hidden hidden
Non current assets held for sale hidden hidden hidden hidden hidden
Deferred tax assets hidden hidden hidden hidden hidden
Product rights and other intangibles hidden hidden hidden hidden hidden
Goodwill hidden hidden hidden hidden hidden
Non current assets hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18), 10-K (filing date: 2014-02-25).


Assets, Selected Items

Item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Allergan PLC's current assets increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Allergan PLC's property, plant and equipment, net increased from 2015 to 2016 and from 2016 to 2017.
Non current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Allergan PLC's non current assets declined from 2015 to 2016 and from 2016 to 2017.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Allergan PLC's total assets declined from 2015 to 2016 and from 2016 to 2017.

Current Assets, Selected Items

Item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Allergan PLC's cash and cash equivalents increased from 2015 to 2016 and from 2016 to 2017.
Marketable securities Amount of investment in marketable security, classified as current. Allergan PLC's marketable securities increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level.
Accounts receivable, net Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Allergan PLC's accounts receivable, net increased from 2015 to 2016 and from 2016 to 2017.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Allergan PLC's inventories declined from 2015 to 2016 but then increased from 2016 to 2017 not reaching 2015 level.